中怡國際(02341.HK)獲授1.85億美元長期貸款融資
格隆匯5月28日丨中怡國際(02341.HK)公佈,於2020年5月27日,由公司為借款人與若干銀行作為放款人訂立貸款協定。根據貸款協定,公司可獲得合共美金1.85億元的長期貸款融資,由首次提款當日起計算為期42個月,並且需要分4期每半年連續償還,第一期、第二期、第三期及第四期的還款日期分別為提款首日後滿24個月、30個月、36個月及42個月當日償還,還款金額分別為貸款本金之12.5%、12.5%、27.5%及47.5%。如果公司行使延長貸款期限的權利,原來需要在第四期還款的金額可以延長至提款首日後第42個月至60個月之期間分4期每半年連續償還。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.